Longest Follow-Up for ICI Plus TKI Favours Treatment with Avelumab Plus Axitinib Combination versus Sunitinib in Patients with Advanced RCC By Ogkologos - February 11, 2025 931 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a final analysis of the JAVELIN Renal 101 study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR What Should People With Cancer Know About Alkaline Water? February 16, 2021 The UK Government’s spending review: Time to invest in the future... October 20, 2020 Detecting multiple cancers with a ‘simple’ blood test: Where are we? April 14, 2022 What to Say to Someone With Cancer: A Patient Perspective July 14, 2022 Load more HOT NEWS Giving Birth Before Age 20 Cuts Breast Risk By 50%, And... 40 K9 Officers Line Up Outside Terminally Ill Girl’s House For... Tratamiento agnóstico contra el cáncer: perspectiva de un experto Immune Pathways Help Identify Patients with Cancer and HIV Most Likely...
